|
Issue |
Title |
|
No 20 (2021) |
Dual anti-HER2 blockade in late-line treatment of metastatic HER2-positive breast cancer |
Abstract
PDF (Rus)
|
M. A. Frolova, M. B. Stenina |
|
No 20 (2021) |
Clinical case of the treatment of metastatic luminal breast cancer |
Abstract
PDF (Rus)
|
A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov |
|
No 20 (2021) |
Рembrolizumab as second line therapy for hepatocellular patient |
Abstract
PDF (Rus)
|
I. A. Dzhanyan, V. V. Breder, O. I. Borisova, K. K. Laktionov |
|
1 - 3 of 3 Items |
|